Understanding the Gaps in Specialty Palliative Care for Cancer Patients
Many cancer patients miss out on vital palliative care.
J. Brian Cassel, Donna McClish, David Buxton, Leanne Yanni, Seth Roberts, Nevena Skoro, Peter May, Egidio Del Fabbro, Danielle Noreika
― 7 min read
Table of Contents
- What is Specialty Palliative Care?
- The Issue at Hand
- The Need for Better Data
- Our Study
- Data Collection
- Inclusion and Exclusion Criteria
- Patient Characteristics
- Use of Hospitals and SPC
- Timing of Specialty Palliative Care
- Factors Associated with SPC Use
- What Does This All Mean?
- The Bigger Picture
- Limitations of Our Study
- Future Directions
- Conclusion
- Original Source
Have you ever wondered what happens when someone is seriously ill, especially with cancer? Well, there's a special kind of care called specialty palliative care (SPC) that helps Patients manage their symptoms and improve their quality of life. It’s like having a friendly guide to help you through the rough waters when life gets a little too stormy.
But here's the kicker: even though SPC is known to help patients and their families feel better, many people who need it don’t receive this type of care. In fact, only about one in four cancer patients in a specific area actually got it. Now, why is that? Let's dig deeper into this mystery of healthcare.
What is Specialty Palliative Care?
SPC is a specialized type of care aimed at improving the overall comfort of patients who are facing serious illnesses. Think of it like having a team of Support specialists, including doctors and nurses, who know just how to make you feel more at ease. They help with things like managing pain, addressing emotional needs, and making sure patients get the support they require as they navigate their illness.
The Issue at Hand
Over the last couple of decades, the availability of SPC has improved in the United States and beyond. However, despite this increase, many cancer patients who could benefit from it do not receive it. Some may prefer other treatments, while others may not even know that this type of support is available. On top of that, there are problems like a lack of resources, low referral rates by doctors, and gaps in knowledge about SPC among patients.
Additionally, Access to SPC can vary based on several factors, such as the type of cancer, a person’s race or ethnicity, their economic status, and whether they live in a city or a rural area. This leads to potential fairness issues in who gets access to this vital care.
The Need for Better Data
To solve the puzzle of SPC access, we need better information. Understanding who receives SPC and what factors influence that can shine a light on the disparities in care. For example, it’s not easy to track how many people with cancer get SPC because they often receive treatments in various locations without connected data.
Our exploration focused on the Richmond-Petersburg metropolitan area in Virginia from 2010 to 2015. The goal was to figure out how many cancer patients used SPC and what factors were associated with its use.
Our Study
We conducted a study using various databases, including a statewide cancer registry and hospital discharge data. In our area, the population was diverse, with around 1.3 million residents. This area had a higher percentage of Black individuals and faced specific health challenges.
We collected information about cancer patients who had died in recent years and looked at their demographics, types of cancer, and how often they received SPC.
Data Collection
To gather data, we used several sources. First, the Virginia Cancer Registry provided information on adults who passed away from cancer between 2012 and 2015. We also tapped into statewide hospital records and details about SPC encounters from local medical groups.
This process allowed us to get a clearer picture of how patients interacted with hospitals and SPC services. We verified that there were only a few hospitals in our region offering SPC, and we confirmed their services were available during our study period.
Inclusion and Exclusion Criteria
To create our study group, we identified cancer patients who were at least 21 years old at the time of diagnosis and died between 2012 and 2015. We made sure to exclude cases that were treated in certain healthcare systems and those with non-melanoma skin Cancers. Ultimately, we focused on 12,030 cancer patients.
Patient Characteristics
The patients we studied had various backgrounds and health issues. The average age was 68 at diagnosis and 74 at death. About half of them spent more than five days in the hospital during their last six months of life. Interestingly, a significant number had a cancer type that was known to respond poorly to treatment.
Use of Hospitals and SPC
We also examined hospitalizations before death. Most of the patients had been admitted to hospitals in the months leading up to their passing. Even among those who were hospitalized, there was a considerable number who did not access SPC when it was available.
For instance, while many of them stayed in hospitals providing SPC services, a notable portion still didn't get the care. This raises questions about why SPC isn't being used more effectively in these situations.
Timing of Specialty Palliative Care
The timing of SPC use was quite revealing as well. On average, patients waited about 4.5 years from their cancer diagnosis to their first encounter with SPC. Additionally, many only started receiving this care very close to their time of death. In fact, half of the patients who accessed SPC did so within the last month of life.
Now, that’s a little concerning, isn’t it? It seems that even when patients had the option of getting this supportive care, they often did so at the very end.
Factors Associated with SPC Use
Our analysis showed that being younger, having a specific type of cancer, and living in areas that weren’t too rural were linked to a higher likelihood of using SPC. Interestingly, being Black also played a role, as Black patients were more likely to receive SPC than their white counterparts.
This contrasts with other studies that show lower hospice use among Black patients, which is puzzling. It highlights the complexities of healthcare access and decisions in different communities.
What Does This All Mean?
From our study, we learned that there are several factors at play when it comes to accessing SPC. The good news is that the percentage of cancer patients receiving it has improved slightly in recent years. However, a significant portion still doesn’t get the help they need in a timely manner.
Is it the culture around cancer care? Is there a lack of awareness? Or maybe a bit of both? These questions are crucial to address to ensure that all patients can benefit from the support they require.
The Bigger Picture
Our investigation is part of a larger effort to tackle health disparities in cancer care. By understanding who is receiving SPC and when, we can identify areas for improvement. It’s about making sure everyone has the opportunity to access this important support, regardless of their background or where they live.
Limitations of Our Study
While we gathered useful data, it’s important to point out some limits. We focused only on one metropolitan area, so our findings might not represent what’s happening elsewhere. Additionally, while we considered many factors, such as socio-economic status, our data on these elements was measured at a broader level.
Future Directions
Looking ahead, more studies are needed to explore how SPC can be better integrated into cancer care. By using similar population-based methods in other regions, we can gain a clearer understanding of how to improve access and timing for palliative care.
Conclusion
In conclusion, our study highlights the need for continued efforts to improve the uptake of specialty palliative care among cancer patients. While some progress has been made, there’s still a lot of work to be done. Everyone deserves to have a supportive care team by their side, helping them navigate the stormy seas of serious illness. It’s time to make SPC a standard part of cancer care so that future patients feel the love and support they need when it matters most.
Title: Specialty palliative care use among cancer patients: A population-based study
Abstract: BackgroundRigorous population-based assessments of the use of specialty palliative care (SPC) in the US are rare. Settings/subjectsThis study examined SPC use among cancer patients in a mid-sized metropolitan area in Southeast US. MeasurementsIn this cancer decedent cohort study, data were acquired and linked from the state-wide cancer registry; state-wide hospital discharge dataset; and local SPC providers. Results12,030 individuals with cancer were included in this study; only 2,958 (24.6%) used SPC. Of the 9,072 persons who did not use SPC, 3,877 (42.7%) went only to hospitals that did not offer SPC; and 3,517 (38.8%) went to hospitals that offered SPC but did not use it. About half of SPC recipients (1493; 50.5%) first received SPC in the final 30 days of life, including 768 (26.0%) in the final week of life. Characteristics associated with using SPC use included being in an socio-economic status quintile other than the lowest; being younger; being Black; having a solid (versus hematological) cancer; having a shorter survival with cancer; dying in the latter two years of the study; being from an area of low or complete rurality; having a hospital admission in the final 60 days prior to initiation of PC or death; having more days in hospital; and living within 15 miles of a hospital offering SPC. ConclusionsIn this population-based study, only one-quarter of cancer patients used SPC, and for half who did so, it came in the final 30 days of life. Key MessageThis novel population-based study found that about 25% of cancer patients who died 2012-2015 had used of specialty palliative care (SPC). Half of them first received SPC in the final month of life. Characteristics associated with SPC included being Black, younger, and residing within 15 miles of a hospital offering SPC.
Authors: J. Brian Cassel, Donna McClish, David Buxton, Leanne Yanni, Seth Roberts, Nevena Skoro, Peter May, Egidio Del Fabbro, Danielle Noreika
Last Update: 2024-11-04 00:00:00
Language: English
Source URL: https://www.medrxiv.org/content/10.1101/2024.10.31.24316547
Source PDF: https://www.medrxiv.org/content/10.1101/2024.10.31.24316547.full.pdf
Licence: https://creativecommons.org/licenses/by/4.0/
Changes: This summary was created with assistance from AI and may have inaccuracies. For accurate information, please refer to the original source documents linked here.
Thank you to medrxiv for use of its open access interoperability.